Skip to content
DataLookout
Menu

NCT07768267

Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome

StatusRecruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Trial status changed: Enrolling by Invitation → Recruiting
    • Site details revised
  2. Notable Enrolling by invitation only
    • Start date changed from estimate of Nov 1, 2026 to Oct 26, 2026
    • Site contact updated
  3. Notable Start date pushed from Oct 1, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 20 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Publications: details revised at 1 of 1 entry
  4. Notable Primary and study completion dates pushed to Dec 31, 2027
    • Start date: Sep 1, 2026 to Oct 1, 2026
    v4
  5. Minor Site contact updatedv3
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of Participants With Remission of Small Intestinal Bacterial Overgrowth
Timeframe: Day 28

Secondary (3)

Change From Baseline in Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) Score
Change From Baseline in Gut Microbial Composition
Irritable Bowel Syndrome Quality of Life questionnaire (IBS-QOL)

Arms and interventions

Biocidin REMOVEExperimental

Participants receive Biocidin REMOVE capsules, a herbal preparation supplied as a 665 mg capsule containing 325 mg of the active proprietary blend. Dosing begins with a 9-day titration, increasing by one capsule every three days: one capsule once daily on Days -9 to -7, one capsule twice daily on Days -6 to -4, and two capsules in the morning with one in the evening on Days -3 to -1. Participants reach the target dose of two capsules twice daily on Day 1 and continue at that dose through Day 28. Capsules are identical in appearance to placebo.

PlaceboPlacebo comparator

Participants receive matching placebo capsules, identical in appearance to Biocidin REMOVE and containing no active ingredients. Placebo follows the same 9-day titration and dosing schedule as the experimental arm: one capsule once daily on Days -9 to -7, one capsule twice daily on Days -6 to -4, two capsules in the morning with one in the evening on Days -3 to -1, then two capsules twice daily on Days 1 through 28.

Drugs: Biocidin REMOVE, Placebo

Sites

1 site in 1 country

  • Johns Hopkins HospitalBaltimore, Maryland, United States